ORIX Corp (ORXCF) stock analysis
Close on Oct 19, 2026Market cap $43.40BP/E –Yield 2.50%
StockData Score
Prices as of Oct 30, 2026How the score works
Weak6 of 30 checks passed
ORIX passes 6 of the 30 checks behind our score; 16 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 1/6
- Past performance
- 3/6
- Financial health
- 2/6
- Dividend
- 0/6
What stands out
Low debt
Debt is 12.8% of shareholders' equity, under the 40% we consider low.
Earnings grew over 5 years
Net income grew 18.4% a year on average over the last five fiscal years.
Earnings growth accelerating
Net income grew 27.2% over the last twelve months, against a 5-year average of 18.4% a year.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 239% of total debt.
What to watch
Return on equity under 15%
Return on equity was 10.4% over the last twelve months and averaged 9.4% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 8.5%, below the 10% that usually covers the cost of capital.
Revenue growing under 10% a year
Revenue grew 7.7% a year over the last three fiscal years, short of the 10% we look for.
Interest not well covered
Operating income covers interest expense 2.4 times; we look for at least 5.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth1/6
Revenue growing under 10% a year
Revenue grew 7.7% a year over the last three fiscal years, short of the 10% we look for.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings growth accelerating
Net income grew 27.2% over the last twelve months, against a 5-year average of 18.4% a year.
Growing slower than the industry
Revenue grew 15.9% over the last twelve months; the Non-depository Credit Institutions median is 19.6%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
This company does not report gross profit.
Past performance3/6
Return on equity under 15%
Return on equity was 10.4% over the last twelve months and averaged 9.4% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 8.5%, below the 10% that usually covers the cost of capital.
Return on equity below the industry
ORIX's return on equity of 10.4% is below the Non-depository Credit Institutions median of 11.3%.
Earnings grew over 5 years
Net income grew 18.4% a year on average over the last five fiscal years.
Net margin above its 5-year average
Net margin was 13.4% over the last twelve months, against a 5-year average of 12.3%.
Net margin above the industry
ORIX's net margin of 13.4% is above the Non-depository Credit Institutions median of 11.6%.
Financial health2/6
Low debt
Debt is 12.8% of shareholders' equity, under the 40% we consider low.
Debt rising against equity
Debt to equity rose from 10.1% five years ago to 12.8%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 239% of total debt.
Interest not well covered
Operating income covers interest expense 2.4 times; we look for at least 5.
Short-term liquidity
The balance sheet is not split into current and non-current items.
Bankruptcy risk (Altman Z)
Needs market value, working capital and retained earnings.
Dividend0/6
No dividend
ORIX has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for ORIX. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $11.84M
- Value traded per 1% price move
- $9.36M
Downside
Medium risk
- Typical loss in a bad month
- 16.2%
- Volatility (annualized)
- 29%
- Sharpe ratio, 1 year
- 1.64
- Beta to the S&P 500 (5Y)
- 0.73
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +15.9% | +7.7% | +7.8% | +3.5% | |
| Operating income | +37.5% | +10.7% | +12.0% | +4.7% | |
| Net income | +27.2% | +15.5% | +18.4% | +5.6% | |
| Dividend per share | +28.5% | +19.2% | +14.8% | +10.1% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 11.3% | 6.4% | 10.4% | |
| Return on assets | 2.5% | 1.4% | 2.6% | |
| Interest coverage | 4.5× | 3.3× | 2.4× | |
| Inventory turnover | 3.5× | – | – | |
| Diluted shares | 1.31B | 1.24B | 1.12B |
Cash use needs five years of cash flow figures
ORIX does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 13.4% | 0.19× | 4.07× | 10.4% |
| FY2024 | 12.2% | 0.17× | 4.13× | 8.8% |
| FY2023 | 12.3% | 0.18× | 4.22× | 9.2% |
| FY2022 | 10.9% | 0.18× | 4.35× | 8.5% |
| FY2021 | 12.7% | 0.18× | 4.43× | 10.1% |
| FY2020 | 8.4% | 0.17× | 4.42× | 6.4% |
| FY2019 | 13.3% | 0.18× | 4.29× | 10.3% |
| FY2018 | 13.3% | 0.21× | 4.23× | 11.6% |
| FY2017 | 10.9% | 0.25× | 4.37× | 12.1% |
| FY2016 | 10.2% | 0.24× | 4.61× | 11.3% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero¥447.27B
- Cash generatingOperating cash flow above zero¥1.37T
- Return on assets improvedROA up on the prior year2.2% → 2.7%
- Earnings backed by cashOperating cash flow above net income¥1.37T vs ¥447.27B
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise1.14B → 1.12B
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.18 → 0.20